#news #biotech Novartis-backed Gamida Cell gains $40M for phase 3 work

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novartis-backed Gamida Cell gains $40M for phase 3 work .Gamida Cell has upped its financing by $40 million in its latest funding round as it preps for final work on a late-stage stem cell blood cancer therapy.

from FierceBiotech: Biotech http://ift.tt/2sOrXS0